Year-over-year earnings per share growth for the last twelve months: Immunocore Holdings plc (IMCR)

immunocore.com (IMCR) - corporate logo

Immunocore Holdings plc generates revenue through the commercialization of KIMMTRAK, an innovative therapy for uveal melanoma. The volatility of the quarterly EPS reflects the dynamics of these sales, while -7776.90 shows the current value of the metric. Supply stability is ensured by redundant lines and reliable operators. Scientific potential is supported by the synergy of the European academic school and attractive options for leading immunologists.

Immunocore Holdings (IMCR) Year-over-year net earnings per share growth for the last 12 months: for the period 07/04/2022 - 11/18/2026

Comprehensive metric breakdowns and analytics for immunocore.com (IMCR)

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Comprehensive company analysis:Immunocore Holdings, IMCR
Manufactured product of Immunocore Holdings plc

To minimize investment risks, it is essential to separate market noise from the issuer's actual performance. This metric measures the percentage change in net earnings per share between the current and previous quarters. By analyzing the recorded quarterly EPS growth, an investor assesses the pace of business scaling. For Immunocore Holdings plc (IMCR), this trend reflects the commercial success of the drug Kimmtrak. Positive momentum confirms the effectiveness of T-cell therapies and the inflow of capital from partners.

Competitors of Immunocore Holdings plc

IBRX: Quarterly EPS earnings growth|JANX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months arcusbio.com|Year-over-year net earnings per share growth for the last 12 months zymeworks.com (ZYME)|Year-over-year earnings per share growth for the last twelve months Tango Therapeutics Inc (TNGX)|Year-over-year net earnings per share growth for the last 12 months Iovance IOVA|Immatics NV - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Xencor Inc. XNCR|CMPX - Year-over-year earnings per share growth for the last twelve months|REPL (replimune.com) - Year-over-year earnings per share growth for the last 12 months|Lyell Pharma (LYEL) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Innate Pharma, S.A. (IPHA)|Year-over-year net earnings per share growth for the last 12 months PYXS|CGEN - Net earnings per share growth for the trailing year|Year-over-year net earnings per share growth for the last 12 months IOBT (IO Biotech Corp)|Year-over-year earnings per share growth rate for the last twelve months STRO|Quarterly EPS earnings growth INKT (MiNK Therapeutics)|Year-over-year earnings per one share growth for the last 12 months HOWL|Immix - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months ALX Oncology Holdings Inc.|CUE: Quarterly EPS earnings growth|PDS Biotech - Year-over-year earnings per one share growth for the last 12 months|SONN (Sonnet BioTherapeutics Holdings Inc.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth MAIA Biotech|Year-over-year earnings per share growth for the last twelve months Liminatus Pharma LLC (LIMN)|LVTX: Year-over-year net earnings per share trend for the last twelve months|NextCure Inc - Year-over-year net earnings per share growth for the last 12 months|Leap Therapeutics, Inc. (LPTX) - Earnings per share growth in annualized terms for the last twelve months|Intensity Therapeutics Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months senseibio.com SNSE|TOVX: Quarterly EPS earnings growth|Gritstone bio Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months KA|Year-over-year earnings per share growth for the last 12 months NEXI (NexImmune, Inc.)|Year-over-year earnings per share growth for the last twelve months Turnstone Biologics Corporation (TSBX)|Year-over-year net earnings per share growth for the last 12 months Vaccinex VCNX|Year-over-year earnings per share growth for the last twelve months harpoontx.com HARP